Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Researcher Manuel Requena awarded with a prize in the Mutual Medical Research Awards 2019

Mutual Mèdica presented its Research Grants and Awards in a ceremony in which the researcher Manuel Requena, from the VHIR Ictus research group, was awarded a second prize.

News

The 13th International Notes-WIDER-Barcelona Course has presented the most innovative techniques in endoluminal endoscopic surgery

Vall d'Hebron hosted the 13th edition of the International Notes-WIDER-Barcelona course, which includes conferences and practical workshops on gastroenterology and surgery and digestive endoscopy

News

Researchers, doctors and patients are encouraging to donate to fight against women's cancer at Giving Tuesday

Vall d'Hebron joins the #GivingTuesday movement with the campaign "Sueño de colores" to raise funds for the fight against cancer of women

News

Four professionals and a medical team from Vall d'Hebron receive the COMB Professional Excellence Awards

The College of Doctors of Barcelona has distinguished the exemplary trajectory and the quality in the medical activity of the winners

News

Dr. Ignacio Ferreira receives a grant from the Merck Salud Foundation to develop a monitoring app on patients with cardiovascular diseases

The objective of the project is to evaluate the impact of remote monitoring (through an app) of patients who have undergone a coronary syndrome.

News

Dr. Tabernero, Dr. Montalbán and the Dr. Felip, among the most cited scientists in the world in 2019

These are the doctors Xavier Montalbán, Josep Tabernero and Enriqueta Felip. To prepare the ranking published by Clarivate Analytics, the count of appointments in the last decade has been used.

News

Managing Zileuton by means of polymeric micelles significantly reduces the tumor stem cells of breast cancer within the tumor and in the bloodstream

Zileuton administered in polymer micelles better reaches the inside of the tumor reducing the amount of CSC within the tumor as well as circulating tumor cells.

News

VHIR participates in a study that characterizes the consequences of the molecular alterations of the ATRX gene in adolescents and young adults who suffer from neuroblastoma

The Translational Research in Child and Adolescent Cancer group has participated in a collaborative study to determine the effects of alterations in the ATRX gene in neuroblastoma

News

We open the exhibition of scientific photography "And what do you see?"

The exhibition collects the scientific photographs of the twelve finalists of the photographic competition that we organized last year among our professionals.

News

Vall d'Hebron launches a campaign to promote the investigation of dystonia in childhood

The campaign #MoutePerLaDistonia, in collaboration with El Celler de Can Roca, wants to raise euros 90.000 for a research project that aims to improve the diagnosis and treatment of dystonia.

News

The research in Digestive Transplants of Vall d'Hebron awarded with the scholarship of the Spanish Society of Hepatic Transplant

On the 17th of October, the FSETH 2019 fellowships of the Spanish Society of Hepatic Transplantation (SETH) were awarded in the framework of the 27th SETH Congress in Seville.

News

New antitumoral drug release strategy created for breast cancer treatment

For this study, inclusion bodies containing p31 proteins, which causes cell apoptosis, and Omomyc, a drug that interferes with the function of the Myc oncogene were manufactured.

News

Two VHIR researchers awarded a Gilead Scholarship

The doctors Maria José Buzón, responsible for Translational Research of HIV and Mar Riveiro, the main researcher of the group of Hepatic Diseases, have been awarded a scholarship of euros 50,000 each

News

Dr. Lucas Moreno leads a relapse neuroblastoma trial

A clinical trial led by Dr. Lucas Moreno has shown promising results in the treatment with the bevacizumab drug for patients with relapsing neuroblastoma or resistant to treatment

News

A single fecal microbial transplant can modulate the microbiome and improve the clinical manifestations of colitis in an animal model

The transplantation of the fecal microbiota restores the intestinal microbiota and, in combination with anti-inflammatory drugs, can be a good candidate for treatment for inflammatory bowel diseases.

News

VHIR receives almost € 700.000€ from La Marató 2018 for two research projects in pediatric oncology

The projects of Dr. Soledad Gallego and Dr. Josep Roma has been awarded for his excellence in research and the funding granted will allow them to improve the treatments and the quality of life of the children.

News

Rivaroxaban would almost double the risk of recurrent thrombosis in patients with antifosfolipid antibody syndrome compared with warfarin

Rivaroxaban does not show inferiority compared to vitamin K (warfarin) antagonists for the treatment of antifosfolipid antibody syndrome.

News

VHIR signs a donation agreement with the Assisted Human Reproduction Center of Barcelona

This research scholarship aims to study and deepen the knowledge of the antibodies that are believed to cause trophoblast injury and / or placental vessels

News

The Asociación Pulseras Candela will finance €150,000 a VHIR research project in a type of pediatric tumor of the central nervous system

Pediatric ependymoma is a highly aggressive tumor of the central nervous system that remains incurable in approximately 40% of cases.

News

More than 150 people discover the interior of Vall d'Hebron during the 48H Open House BCN

At the VHIR, visitors could know the crop room, the Neuromuscular and Mitochondrial Pathology Laboratory, the freezer room and the High Technology Unit,